Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
DexCom Inc
DXCMCurrent price
68.11 USD
+1.66 USD (+2.50%)
Last closed
65.68 USD
Company
www.dexcom.com
ISIN
US2521311074
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Capitalization
26 864 738 304 USD
Yield for 12 month
-18.92 %
1Y
3Y
5Y
10Y
15Y
DXCM
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California. Address: 6340 Sequence Drive, San Diego, CA, United States, 92121
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
97.25 USDP/E ratio
41.6398Dividend Yield
–Current Year
+3 622 300 000 USD
Last Year
+2 909 800 000 USD
Current Quarter
+1 004 300 000 USD
Last Quarter
+921 000 000 USD
Current Year
+2 288 900 000 USD
Last Year
+1 883 100 000 USD
Current Quarter
+626 700 000 USD
Last Quarter
+561 900 000 USD
Key Figures DXCM
1 year
3 years
5 years
10 years
EBITDA
886 800 000 USD
Operating Margin TTM
PE Ratio
41.6398
Return On Assets TTM
6.26 %
PEG Ratio
1.0387
Return On Equity TTM
29.41 %
Wall Street Target Price
97.25 USD
Revenue TTM
3 934 799 872 USD
Book Value
6.08 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
15.3 %
Dividend Yield
–
Gross Profit TTM
1 883 100 000 USD
Earnings per share
1.61 USD
Diluted Eps TTM
1.61 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
26.6 %
Profit Margin
16.95 %
Dividend Analytics DXCM
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History DXCM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
4:1
Payout Ratio
–
Last Split Date
13.06.2022
Dividend Date
–
Stock Valuation DXCM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
41.6398
Forward PE
32.3625
Enterprise Value Revenue
6.7191
Price Sales TTM
6.8275
Enterprise Value EBITDA
25.6336
Price Book MRQ
11.0771
Financials DXCM
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators DXCM
For 52 weeks
62.34 USD
142 USD
50 Day MA
74.51 USD
Shares Short Prior Month
7 334 153
200 Day MA
112.06 USD
Short Ratio
2.1
Shares Short
8 551 679
Short Percent
2.41 %
BeatStart